Medtech Insight is pleased to invite you to attend its 9th "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference to be held October 30^th and 31^st, 2003, at the Westin Copley Place Hotel in Boston, Massachusetts. Over 50 companies representing a wide variety of high-growth clinical areas will present their innovative technologies at In3 Boston.  Planned coverage includes presentations on a range of advanced technologies and clinical areas, including cardiovascular surgery and interventional cardiology, biomaterials, orthopedic surgery, critical care technology, and minimally invasive surgery, among many others.

Our June 2003 conference in San Francisco drew record attendance—don’t miss this opportunity to grow your business by aligning with the leading medical technologies of tomorrow!

Medtech Insight is honored to have Robert S. Langer, Sc.D., Germeshausen Professor of Chemical & Biomedical Engineering, from the Massachusetts Institute of Technology, an expert on medical technology patenting and past chairman of the FDA’s highest advisory board, the SCIENCE Board, as the keynote speaker for the conference. This event is co-sponsored by AdvaMed, Battelle, Clinsights, Hale and Dorr LLP, LyChron, Medmarc and The Hartford, Pittsburgh Life Sciences Greenhouse, PRNewswire, Reimbursement Principles, Ronald Trahan Associates, The MedTech Group, Underwriters Laboratories, Windhover Information, and ZEVEX.

REGISTER BY AUGUST 29TH AND SAVE $200

This two-day event will highlight emerging technologies being developed by more than 50 small, mostly privately-held medical technology companies seeking partnering and/or investment. The meeting will draw an attendance of up to 300 senior executives from the investment community as well as major medical technology, biopharmaceutical, biotech, and other companies.

Tap into the opportunities about to emerge in the medical industry marketplace! Planned coverage includes presentations on a range of advanced technologies and clinical areas.

Network with presenting companies and attendees. More than 50 companies are slated to present at our meeting in Boston (check back often, as we will keep an updated list posted online http://www.medtechinsight.com/in3-09.html ). The forum will provide focused overviews by a senior executive from each company, followed by the opportunity to meet one-on-one in private breakout rooms.

The presenting companies include:

Acorn Cardiovascular, Inc. -- (technology description available soon)

Actuality Systems, Inc. -- globe-shaped visualization system compatible with 3D DICOM data for angiography, catheterization, CT, PET, and MRI

Angiogene, Inc. -- (technology description available soon)

Biophan Technologies, Inc. -- technology to resolve MRI safety issues and improve image quality of metal implants/interventional medical tools

Biowave Corporation -- pain management therapies

Comedicus, Inc. -- devices that access the pericardial space creating a new pathway to treat/diagnose heart disease

Confluent Surgical, Inc. -- in-situ-polymerized biomaterials therapy for the prevention of post-surgical adhesions

Design & Performance Canada, Inc. -- Coronary Over and Under Bovine Pericardium covered stent for treating saphenous vein grafts, aneurysms, and perforations

Devax, Inc. -- bifurcation stent for coronary and peripheral vascular use

Disc Dynamics, Inc. -- Dascor arthroplasty system, spinal implants technology

ECI Biotech -- bacterial detection technologies for point-of-care diagnostics and therapeutic applications

EP Limited -- enhanced RF ablation technology for treating liver cancer and ventricular tachycardia

Florence Medical, Inc. -- SmartFlow cath lab products for the treatment of coronary and peripheral vascular disease

Genomic Profiling Systems, Inc. -- (technology description available soon)

ImageGuide, Inc. -- (technology description available soon)

InfraReDx, Inc. -- fiber-optic, catheter-based, near infrared (NIR) system to identify and stabilize vulnerable plaques in coronary arteries

Intelligent Medical Devices, LLC -- (technology description available soon)

Interventional Imaging, Inc. -- technology to prevent heart attacks through detection/treatment of vulnerable plaque in the coronary arteries

Medihale, Ltd. -- inhalation drug delivery technology

MR Instruments, Inc. -- MRI technology that creates a better image, more applications, lowers costs, and improves patient outcomes

N-Dia, Inc. -- accurate, rapid, and noninvasive detection of premature rupture of fetal membranes, a common pregnancy complication

Pelikan Technologies, Inc. -- hand-held medical devices including automated lancing device and one-step integrated blood glucose monitor

Physiometrix, Inc. -- level of sedation monitor enabling clinicians to titrate drugs in the OR, ICU, and Outpatient Surgery

Power Medical Interventions, Inc. -- digital and wireless medical technology for advanced minimally invasive procedures

SleepUp, Ltd. -- devices for the treatment of obstructive sleep apnea

Tayside Flow Technologies, Ltd. -- Spiral Laminar Flow (SLF) technology for minimization of vascular occlusion following surgical intervention

Vascular BioSciences, Inc. -- endoarterial biopsy catheter to improve the clinical outcomes of vascular-based disease patients

Vertebron, Inc. -- spinal orthopaedic implants, spanning fusion (pedicle screws, cervical plates, interbody), and motion preservation (artificial discs)

Vertelink Corporation -- minimally invasive multi-level percutaneous spinal fixation and fusion systems and devices

Xillix Technologies Corporation -- endoscopy systems allowing physicians to see very small, early-stage cancer and subtle pre-cancerous lesions

Since 2001, our conferences have drawn 2,300 attendees and over 300 innovative early-stage presenting companies. Take a look at our last In³ conference.

Register by August 29, 2003 and pay only $1,195 per attendee (a $200 discount off the full registration price of $1,395)!

To suggest a presenting company or speaker, please e-mail sales@medtechinsight.com.

An ideal forum for:

• Investment Opportunities
• Business Development/Strategic Partnering Opportunities
• Networking with Industry Leaders

Who should attend:

• Medical device executives seeking insight into emerging medical technologies
• Venture capitalists and investment bankers
• Established medical product companies seeking licensing, partnering, and acquisition opportunities

This meeting will feature:

• 10-minute presentations from 50 innovative, early-stage medical technology companies seeking partnership and/or investment, followed by private breakout sessions
• Attendance by hundreds of industry leaders and senior executives from the top medical technology and investment firms
• Coverage on a wide range of advanced technologies and clinical areas
• Table-top exhibits and product prototypes will be displayed by presenting companies during a networking buffet dinner on Thursday evening, October 30, 2003.

Keynote Speaker:

Robert S. Langer, Sc.D., Germeshausen Professor of Chemical & Biomedical Engineering, Massachusetts Institute of Technology
“Creating and Developing New Medical Technologies”

Featured Speaker:

Michael Carusi, General Partner, Advanced Technology Ventures

“The Current and Future Outlook for Healthcare Investing”

(Other speakers to be announced)

Since the inception of the “Investment In Innovation (In3)” meeting series in January 2001, over 300 early-stage emerging medical technology companies have presented and 2,300 medical technology executives and investors have attended, making it the premier forum for partnering and business development.  Don’t miss this unique opportunity to network with industry leaders and tap into another innovative group of emerging medical technology companies.

REGISTRATION INFORMATION

To register, or to find out who else will be in attendance and why you should attend, e-mail in3@medtechinsight.com or call (949) 219-0150, (888) 290-2225 toll-free in the U.S. We look forward to seeing you in Boston this October!

• Registration Rate through August 29th:  $1195
• Registration Rate after August 29th: $1395

Medtech Insight is publisher of the monthly “medtech insight” newsletter, covering the latest discoveries, trends and innovations in the medical technology industry. The company publishes analyses of medical technology markets through its Reports group, holds "Investment In Innovation" (In³) conferences for emerging medical technology companies in need of funding, acquisition or strategic alliance, and offers custom market research via its Consulting group. For more information on the upcoming In3 conference or Medtech Insight’s other products and services, call (949) 219-0150, (888) 290-2225 toll-free in the U.S., fax (949) 219-0067, or e-mail in3@medtechinsight.com. Visit the company's website at http://www.medtechinsight.com  to read more about the company's products, download a sample newsletter issue, or to sign up for a free monthly e-mail newsletter summary.

To attend this conference, you may register online, e-mail sales@medtechinsight.com, or call (949) 219-0150 or (888) 290-2225 (toll free in the U.S.).